# Oramed Pharmaceuticals Inc.: Form 8-K, filed Sep 13, 2023

- Company: [Oramed Pharmaceuticals Inc.](/companies/ormp.md) (CIK 1176309)
- Form: 8-K
- Filed: 2023-09-13
- Accepted by EDGAR: Sep 13, 2023, 08:47 ET
- Period: 2023-09-11
- Accession: 0001213900-23-076238
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1176309/000121390023076238/ea185123-8k_oramed.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1176309/000121390023076238/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1176309/000121390023076238/ea185123-8k_oramed.htm

Filed Sep 13, 2023.
Source: SEC EDGAR, the filing index for accession 0001213900-23-076238. Last ingested by Listed: Nov 15, 2026, 04:14 ET. No prices; not investment advice.
